ArticleArteriosclerosis, thrombosis, and vascular biology2016

Cell-Penetrating Pepducin Therapy Targeting PAR1 in Subjects With Coronary Artery Disease.

Paul A Gurbel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.